Definitive Contract 75F40124C00125

Award Date 9/26/24
Potential Completion Date 9/29/29
Potential Value $1.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Purdue University, a non-profit educational institution, is valued at $794,004.00. The award was made by the Food and Drug Administration (FDA) under its Broad Agency Announcement for Advanced Regulatory Science, which is a research and development program focused on modernizing regulatory science to support the FDA's mission. The contract requires Purdue to construct extensive databases and develop statistical analysis tools using Python and SAS software to...
This is a definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Purdue University, a public land-grant research university. The contract, valued at $128,012.00, is for the performance of inspections of animal food manufacturing facilities to determine compliance with FDA regulations regarding medicated feeds, Food Safety Modernization Act Produce Safety Rule, and Bovine Spongiform Encephalopathy requirements. The contract was awarded on August 31, 2021 and...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Purdue University, a public land-grant research university. The contract is for "HUMAN FOOD INSPECTIONS (EGG ONLY)" with a ceiling value of $865,389.06 and a completion date of October 15, 2027. The contract is a firm fixed-price arrangement with no set-aside designation. Purdue University is an experienced federal contractor and grantee, leveraging its research capabilities...
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract to Purdue University, an institution of higher education and research, to characterize the structure and interactions of carboxymaltose with an iron core. The $667,142.00 cost-no-fee contract, awarded on September 22, 2021, has a completion date of September 29, 2023. This contract is associated with the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research...
This firm fixed-price purchase order contract was awarded by the Food and Drug Administration to Purdue University, a 1862 land grant college and other not-for-profit educational institution located in West Lafayette, Indiana. The $250,000.00 contract is for environmental surveillance of the Indiana melon production agricultural region to detect foodborne bacterial pathogens. The contract does not have a set-aside designation. Based on Purdue University's extensive experience as a prime...
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Purdue University, a not-for-profit educational institution, to provide training and pilot processing laboratory facility services. The contract has a potential value of $783,260.50 and a completion date of March 23, 2023. The original solicitation was a sources sought notice/request for information to identify small businesses capable of providing the...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Rutgers, The State University for an "Integrated Toolbox for Digital Design, Scale-up, Control, and Optimization of Advanced API Manufacturing Processes" with a potential value of $4,198,914.00. The contract is a definitive, cost-no-fee agreement with a completion date of September 30, 2024. Rutgers University is serving as the prime contractor, with Purdue...
This federal contract award was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Purdue University, a nonprofit institution of higher education and research. The $7,000.00 firm fixed-price delivery order is for the provision of tuition and fees, with a period of performance through August 30, 2024. No set-aside designation is mentioned. Purdue University, as the prime contractor, has a broad history of supporting U.S. government missions through...
This is a firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA), Office of Research and Development (R&D) to Purdue University, a 1862 Land Grant College and not-for-profit educational institution. The contract, valued at $307,933.19, is for the generation of the SRT1720 compound to support research and development activities at the Indianapolis VA Medical Center. The procurement was sole-sourced to Purdue University as the developer of the...
This federal contract award to The Trustees of Princeton University, valued at $2,692,771.30, is for an Integrated Platform for Continuous RNA Nanoparticle Formulation and Drying. The award was made by the Food and Drug Administration (FDA) and is not associated with a set-aside program. The contract supports research and development to advance regulatory science in areas of interest to the FDA, as outlined in a Broad Agency Announcement (BAA) solicitation. Key subcontractors include Seran...

The U.S. Food and Drug Administration (FDA) has awarded a Firm Fixed Price Definitive Contract worth $1,531,286.00 to Purdue University to perform research on "ADVANCING BISPECIFIC ENGAGERS FOR NK IMMUNOTHERAPY IN PEDIATRIC GLIOMAS" under Broad Agency Announcement FY24C1BP30. The contract has a period of performance through September 29, 2029. Purdue University, a not-for-profit 1862 Land Grant College and educational institution, will serve as the prime contractor. This award is not associated with any set-aside program. The contract supports the FDA's mission by advancing research into novel immunotherapies for the treatment of pediatric brain cancers.

Generated 9/28/24, 9:30 AM